New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: Long-term impact and utility of the pre-transplant OGTT

International Urology and Nephrology

Volumn 42, Issue 4, 2010, Pages 935-945

  Iida, Shoichi ^a   Ishida, Hideki ^a   Tokumoto, Tadahiko ^a   Omoto, Kazuya ^a   Shirakawa, Hiroki ^a   Shimizu, Tomokazu ^a   Amano, Hiroyuki ^a   Setoguchi, Kiyoshi ^a   Nozaki, Taiji ^a   Toki, Daisuke ^a   Tokita, Daisuke ^a   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

FK506; NODAT; Pre transplantation oral glucose tolerance test; Renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MEDOROL; METHYLPREDNISOLONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; ORAL ANTIDIABETIC AGENT; ORTHOCLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIET RESTRICTION; DISEASE COURSE; DRUG DOSE REDUCTION; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; PATIENT MONITORING; PLASMAPHERESIS; PREOPERATIVE EVALUATION; PROTEIN URINE LEVEL; RISK FACTOR; SURVIVAL RATE;

ADULT; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS; YOUNG ADULT;

EID: 78751650116     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-010-9712-0     Document Type: Article

References (26)

1. ZA Massy BL Kasiske 1996 Post-transplant hyperlipidemia: mechanisms and management J Am Soc Nephrol 7 971 977 1:STN:280:DyaK28vis1ygsw%3D%3D 8829110
2. S Aakhus K Dahl TE Wideroe 1999 Cardiovascular morbidity and risk factors in renal transplant patients Nephrol Dial Transplant 14 648 654 1:STN:280:DyaK1M3gvVWmtQ%3D%3D 10.1093/ndt/14.3.648 10193814
3. BL Kasiske 2000 Cardiovascular disease after renal transplantation Semin Nephrol 20 176 187 1:STN:280:DC%2BD3c3gvVKnug%3D%3D 10746859
4. RM Jindal RA Sidner ML Milgrom 1997 Post-transplant diabetes mellitus. The role of immunosuppression Drug Saf 16 242 257 1:CAS:528:DyaK2sXjtVaitr4%3D 10.2165/00002018-199716040-00002 9113492
5. MR Weir JC Fink 1999 Risk for post transplant diabetes mellitus with current immunosuppressive medications Am J Kidney Dis 34 1 13 1:STN:280:DyaK1MzjtV2jsQ%3D%3D 10.1016/S0272-6386(99)70101-0 10401009
6. AJ Krentz J Dmitrewski D Mayer M Nattrass 1995 Effects of immunosuppressive agents on glucose metabolism Clin Immunother 4 103 123
7. JD Pirsch J Miller MH Deierhoi F Vincenti RS Filo 1997 A comparison of tacrolimus and cyclosporine for immuno-suppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group Transplantation 63 977 983 1:CAS:528:DyaK2sXjtFerurw%3D 10.1097/00007890-199704150-00013 9112351 (Pubitemid 27173021)
8. AD Mayer J Dmitrewski JP Squifflet T Besse B Grabensee B Klein, et al. 1997 Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European tacrolimus Multicenter Renal Study Group Transplantation 64 436 443 1:CAS:528:DyaK2sXlvV2ru78%3D 10.1097/00007890-199708150-00012 9275110 (Pubitemid 27349884)
9. GA Knoll RC Bell 1999 Tacrolimus versus cyclosporin for immunosuppression in renal transplantation: meta-analysis of randomized trials Br Med J 318 1104 1107 1:CAS:528:DyaK1MXjtVyqsL0%3D
10. EM Van Duijnhoven JMM Boots MHL Christiaans BHR Wolffenbuttel JP van Hooff 2001 Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study J Am Soc Nephrology 12 583 588 1:STN:280:DC%2BD3M3mvFSjsw%3D%3D
11. JH Nam JI Mun SI Kim SW Kang KH Choi K Park, et al. 2001 β-cell dysfunction rather than insulin resistance is the main contributing factor for development of postrenal transplantation diabetes mellitus Transplantation 71 1417 1423 1:CAS:528:DC%2BD3MXltVOit7g%3D 10.1097/00007890-200105270-00011 11391229
12. A Ekstrand J Ahonen C Gronhagen-Riska L Groop 1989 Mechanisms of insulin resistance after kidney transplantation Transplantation 48 563 568 1:STN:280:DyaK3c%2FitVCksA%3D%3D 2678633
13. B Fivush OC Green CC Porter JW Balfe S O'Regan WA Gahl 1987 Pancreatic endocrine insufficiency in post transplant cystinosis Am J Dis Child 141 1087 1108 1:STN:280:DyaL2szitlWjuw%3D%3D 3307383
14. G Filler P Amendt MA von Bredow W Rohde JHH Ehrich 1998 Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis Eur J Pediatr 157 738 742 1:CAS:528: DyaK1cXmvVeju7k%3D 10.1007/s004310050926 9776533 (Pubitemid 28419102)
15. O Schmitz L Orskov S Lund N Moller JS Christiansen H Orskov 1993 Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children J Pediatr Endocrinol 6 53 55 1:STN:280:DyaK3szos1aqsA%3D%3D 8374690
16. K Tanabe T Tokumoto H Ishida, et al. 2004 Excellent outcome of ABO incompatible living kidney transplantation under pretransplantation immunosuppression with tacrolimus, mycophenolate mofetil, and steroid Transplant Proc 36 2175 2177 1:CAS:528:DC%2BD2cXpt1aqtLY%3D 10.1016/j.transproceed.2004. 08.142 15518791 (Pubitemid 39424371)
17. H Ishida N Miyamoto H Shirakawa, et al. 2007 Evaluation of immunosuppressive regimens in ABO-incompatible living kidney transplantation-single center analysis Am J Transplant 7 825 831 1:CAS:528:DC%2BD2sXltFOjs7s%3D 10.1111/j.1600-6143.2006.01676.x 17250557 (Pubitemid 46481177)
18. Davidson J, Wilkinson A, Dantal J et al. (2003) New-onset diabetes after transplantation: 2003 International Consensus Guidelines. In: Proceedings of an international expert panel meeting. Barcelona, Spain, February 19, 2003. Transplantation 75(suppl): SS3
19. LC Racusen K Solez RB Colvin, et al. 1999 The Banff 97 working classification of renal allograft pathology Kidney Int 55 713 723 1:STN:280:DyaK1M7ktFGluw%3D%3D 10.1046/j.1523-1755.1999.00299.x 9987096 (Pubitemid 29082898)
20. V Scantlebury R Shapiro J Fung, et al. 1991 New onset of diabetes in FK506 vs cyclosporine-treated kidney transplant recipients Transplant Proc 23 3160 3170
21. JT Mathew M Rao V Job, et al. 2003 Post-transplant hyperglycaemia: a study of risk factors Nephrol Dial Transplant 18 164 171 1:CAS:528: DC%2BD38XpsFOnur8%3D 10.1093/ndt/18.1.164 12480976 (Pubitemid 36104494)
22. J Hjelmesaeth A Hartmann J Kofstad, et al. 1997 Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age Transplantation 64 979 1:CAS:528:DyaK2sXntFSjs78%3D 10.1097/00007890-199710150- 00008 9381545 (Pubitemid 27446762)
23. S Todo JJ Fung TE Starzl, et al. 1990 Liver, kidney, and thoracic organ transplantation under FK 506 Ann Surg 212 295 1:STN:280:DyaK3cznt1OnsQ%3D%3D 10.1097/00000658-199009000-00008 1697743
24. A Suga Y Kishi Y Fujikawa, et al. 2003 Diabetes mellitus after renal transplantation under tacrolimus-based immunosuppression Transplant Proc 35 263 265 1:STN:280:DC%2BD3s%2FotV2qsA%3D%3D 10.1016/S0041-1345(02)03807-1 12591391 (Pubitemid 36194598)
25. S Sezer A Bilgic M Uyar Z Arat FN Ozdemir M Haberal 2006 Risk factors for development of posttransplant diabetes mellitus in renal recipients Transplant Proc 38 529 532 1:CAS:528:DC%2BD28Xis1aqsb0%3D 10.1016/j.transproceed.2005.12. 066 16549166
26. DR Kuypers K Claes B Bammens P Evenepoel Y Vanrenterghem 2008 Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post transplantation diabetes mellitus (PTDM) Nephrol Dial Transpl 23 2033 2042 1:CAS:528:DC%2BD1cXmtlCltrk%3D 10.1093/ndt/gfm875 (Pubitemid 351768147)